title: Polycaprolactone nanofiber interspersed collagen type-I scaffold for bone regeneration: a unique injectable osteogenic scaffold.
abstract: There is an increasing demand for an injectable cell coupled three-dimensional (3D) scaffold to be used as bone fracture augmentation material. To address this demand, a novel injectable osteogenic scaffold called PN-COL was developed using cells, a natural polymer (collagen type-I), and a synthetic polymer (polycaprolactone (PCL)). The injectable nanofibrous PN-COL is created by interspersing PCL nanofibers within pre-osteoblast cell embedded collagen type-I. This simple yet novel and powerful approach provides a great benefit as an injectable bone scaffold over other non-living bone fracture stabilization polymers, such as polymethylmethacrylate and calcium content resin-based materials. The advantages of injectability and the biomimicry of collagen was coupled with the structural support of PCL nanofibers, to create cell encapsulated injectable 3D bone scaffolds with intricate porous internal architecture and high osteoconductivity. The effects of PCL nanofiber inclusion within the cell encapsulated collagen matrix has been evaluated for scaffold size retention and osteocompatibility, as well as for MC3T3-E1 cells osteogenic activity. The structural analysis of novel bioactive material proved that the material is chemically stable enough in an aqueous solution for an extended period of time without using crosslinking reagents, but it is also viscous enough to be injected through a syringe needle. Data from long-term in vitro proliferation and differentiation data suggests that novel PN-COL scaffolds promote the osteoblast proliferation, phenotype expression, and formation of mineralized matrix. This study demonstrates for the first time the feasibility of creating a structurally competent, injectable, cell embedded bone tissue scaffold. Furthermore, the results demonstrate the advantages of mimicking the hierarchical architecture of native bone with nano- and micro-size formation through introducing PCL nanofibers within macron-size collagen fibers and in promoting osteoblast phenotype progression for bone regeneration.
authors.affiliation: Department of Bioengineering, College of Engineering, University of Toledo, Toledo, OH 43606, USA.
authors.forename: Nuray
authors.initials: N
authors.lastname: Baylan
authors.forename: Samerna
authors.initials: S
authors.lastname: Bhat
authors.forename: Maggie
authors.initials: M
authors.lastname: Ditto
authors.forename: Joseph G
authors.initials: JG
authors.lastname: Lawrence
authors.forename: Beata
authors.initials: B
authors.lastname: Lecka-Czernik
authors.forename: Eda
authors.initials: E
authors.lastname: Yildirim-Ayan
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry; D001861:Bone Regeneration; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000737:chemistry; D002460:Cell Line; D049109:Cell Proliferation; D002470:Cell Survival; D003094:Collagen / Q000008:administration & dosage* / Q000737:chemistry*; D024042:Collagen Type I / Q000008:administration & dosage; D005109:Extracellular Matrix / Q000378:metabolism; D008422:Materials Testing; D051379:Mice; D057139:Nanofibers / Q000737:chemistry*; D010006:Osteoblasts / Q000166:cytology; D010012:Osteogenesis; D010641:Phenotype; D011091:Polyesters / Q000737:chemistry*; D019904:Polymethyl Methacrylate / Q000737:chemistry; D013594:Syringes; D023822:Tissue Engineering / Q000379:methods; D054457:Tissue Scaffolds / Q000737:chemistry*
chemical_list: D001672:Biocompatible Materials; D024042:Collagen Type I; D011091:Polyesters; C016240:polycaprolactone; D003094:Collagen; D019904:Polymethyl Methacrylate; D002118:Calcium